Carcinogenesis, Vol 18, 1817-1824, Copyright © 1997 by Oxford University Press
HM Sansbury, AE Wisehart-Johnson, C Qi, S Fulwood and KE Meier
Phorbol ester-sensitive EL4 murine thymoma cells respond to phorbol 12-
myristate 13-acetate with activation of ERK mitogen-activated protein
kinases, synthesis of interleukin-2, and death, whereas phorbol ester-
resistant variants of this cell line do not exhibit these responses.
Additional aspects of the resistant phenotype were examined, using a
newly-established resistant cell line. Phorbol ester induced morphological
changes, ERK activation, calcium-dependent activation of the c-Jun
N-terminal kinase (JNK), interleukin-2 synthesis, and growth inhibition in
sensitive but not resistant cells. A series of protein kinase C activators
caused membrane translocation of protein kinase C's (PKCs) alpha, eta, and
theta in both cell lines. While PKC eta was expressed at higher levels in
sensitive than in resistant cells, overexpression of PKC eta did not
restore phorbol ester-induced ERK activation to resistant cells. In
sensitive cells, PKC activators had similar effects on cell viability and
ERK activation, but differed in their abilities to induce JNK activation
and interleukin-2 synthesis. PD 098059, an inhibitor of the mitogen
activated protein (MAP)/ERK kinase kinase MEK, partially inhibited ERK
activation and completely blocked phorbol ester-induced cell death in
sensitive cells. Thus MEK and/or ERK activation, but not JNK activation or
interleukin-2 synthesis, appears to be required for phorbol ester-induced
toxicity. Alterations in phorbol ester response pathways, rather than
altered expression of PKC isoforms, appear to confer phorbol ester
resistance to EL4 cells.
ARTICLES
Effects of protein kinase C activators on phorbol ester-sensitive and - resistant EL4 thymoma cells
Department of Cell and Molecular Pharmacology, Medical University of South Carolina, Charleston 29425-2251, USA.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. M. Knoepp, M. S. Chahal, Y. Xie, Z. Zhang, D. J. Brauner, M. A. Hallman, S. A. Robinson, S. Han, M. Imai, S. Tomlinson, et al. Effects of Active and Inactive Phospholipase D2 on Signal Transduction, Adhesion, Migration, Invasion, and Metastasis in EL4 Lymphoma Cells Mol. Pharmacol., September 1, 2008; 74(3): 574 - 584. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Han, S. M. Knoepp, M. A. Hallman, and K. E. Meier RasGRP1 Confers the Phorbol Ester-Sensitive Phenotype to EL4 Lymphoma Cells Mol. Pharmacol., January 1, 2007; 71(1): 314 - 322. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q.-B. She, A. M. Bode, W.-Y. Ma, N.-Y. Chen, and Z. Dong Resveratrol-induced Activation of p53 and Apoptosis Is Mediated by Extracellular- Signal-regulated Protein Kinases and p38 Kinase Cancer Res., February 1, 2001; 61(4): 1604 - 1610. [Abstract] [Full Text]
|
|
|
|
 |
|
 H. Ku and K. E. Meier Phosphorylation of Paxillin via the ERK Mitogen-activated Protein Kinase Cascade in EL4 Thymoma Cells J. Biol. Chem., April 6, 2000; 275(15): 11333 - 11340. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. S. Resnick, B.-S. Kang, D. Luu, J. T. Wickham, J. J. Sando, and C. S. Hahn Differential Downstream Functions of Protein Kinase Ceta and -theta in EL4 Mouse Thymoma Cells J. Biol. Chem., October 16, 1998; 273(42): 27654 - 27661. [Abstract] [Full Text] [PDF]
|
|